J. Rubino

发表

Randomized, Controlled Trial of a 13-Valent Pneumococcal Conjugate Vaccine Administered Concomitantly with an Influenza Vaccine in Healthy Adults

E. Emini, A. Gurtman, R. Frenck, 2012, Clinical and Vaccine Immunology.

Concomitantly With Influenza Vaccines in Healthy Adults

E. Emini, A. Gurtman, R. Frenck, 2012 .

Subcutaneous administration of botulinum toxin A reduces formalin-induced pain

K. Aoki, J. Rubino, Minglei Cui, 2004, Pain.

Antihyperalgesic Effects of (R,E)-N-(2-Hydroxy-2,3-dihydro-1H-inden-4-yl)-3-(2-(piperidin-1-yl)-4-(trifluoromethyl)phenyl)-acrylamide (AMG8562), a Novel Transient Receptor Potential Vanilloid Type 1 Modulator That Does Not Cause Hyperthermia in Rats

J. Louis, B. H. Manning, N. Gavva, 2008, Journal of Pharmacology and Experimental Therapeutics.

Lipid lowering with bempedoic acid added to a proprotein convertase subtilisin/kexin type 9 inhibitor therapy: A randomized, controlled trial.

J. Mckenney, N. Lalwani, D. Macdougall, 2021, Journal of clinical lipidology.

Immunogenicity and safety of a second administration of 13-valent pneumococcal conjugate vaccine 5 years after initial vaccination in adults 50 years and older.

E. Emini, A. Gurtman, R. Frenck, 2016, Vaccine.

Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 18-49 years of age, naive to 23-valent pneumococcal polysaccharide vaccine.

E. Emini, A. Gurtman, R. Frenck, 2015, Vaccine.

Blood Pressure Lowering Effects of a New Long-Acting Inhibitor of Phosphodiesterase 5 in Patients With Mild to Moderate Hypertension

D. Xuan, M. Pressler, J. Mancuso, 2009, Hypertension.

Phosphodiesterase-5 Blood Pressure Lowering Effects of a New Long-Acting Inhibitor of Phosphodiesterase 5 in Patients With Mild to Moderate Hypertension

D. Xuan, M. Pressler, J. Mancuso, 2009 .

Bacterial mutagens in the urine of patients under tinidazole treatment.

J. J. Espinosa-Aguirre, J. M. Hernández, J. Rubino, 1996, Mutation research.

Combination of bempedoic acid, ezetimibe, and atorvastatin in patients with hypercholesterolemia: A randomized clinical trial.

S. Nicholls, D. Macdougall, L. Sterling, 2020, Atherosclerosis.

In Vitro Nephrotoxicity and Permeation of Vancomycin Hydrochloride Loaded Liposomes

V. Weissig, M. Joshi, M. Scheetz, 2022, Pharmaceutics.

The rat Digit Abduction Score (DAS) assay: a physiological model for assessing botulinum neurotoxin-induced skeletal muscle paralysis.

K. Aoki, R. Broide, J. Rubino, 2013, Toxicon : official journal of the International Society on Toxinology.

Use of ETC-1002 to treat hypercholesterolemia in patients with statin intolerance.

P. Thompson, M. Janik, D. Macdougall, 2015, Journal of clinical lipidology.

Lipid Lowering With Bempedoic Acid Added to Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Therapy: A Randomized Controlled Trial

J. Mckenney, D. Macdougall, Stephanie Kelly, 2019, Journal of Clinical Lipidology.

Efficacy and Safety of Triplet Therapy With Bempedoic Acid, Ezetimibe, and Atorvastatin in Patients with Hypercholesterolemia

S. Nicholls, D. Macdougall, L. Sterling, 2019, Journal of Clinical Lipidology.

TRPV1 modulator that does not cause hyperthermia in rats

J. Louis, B. H. Manning, N. Gavva, 2008 .

Defining the optimal calcium repletion dosing in patients requiring activation of massive transfusion protocol.

M. Rech, P. Dechristopher, J. Rubino, 2023, American Journal of Emergency Medicine.

Antihyperalgesic Effects of (R,E)-N-(2-Hydroxy-2,3-dihydro-1H-inden-4-yl)-3-(2-(piperidin-1-yl)-4-(trifluoromethyl)phenyl)-acrylamide (AMG8562), a Novel Transient Receptor Potential Vanilloid Type 1 Modulator That Does Not Cause Hyperthermia in Rats

J. Louis, B. H. Manning, N. Gavva, 2008, Journal of Pharmacology and Experimental Therapeutics.